Main > ONCOLOGY (**) > Prostate Cancer mCRPC PSMA+ > CH. N. Treat.>Radioligand Agent IV> > (*) USA Approval Date: 2022. 03.23

---

(*) USA Approval Date: 2022. 03.23's products
This section has no products